Re-appointment of Internal Auditors and Secretarial Auditors for the Financial Year 2025-26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital's board approved audited financial results for the half-year and full year ended March 31, 2025. Revenue from operations grew to Rs. 4,785.33 lakhs from Rs. 4,303.74 lakhs (up ~11.2% YoY), but profit after tax declined to Rs. 420.67 lakhs from Rs. 524.85 lakhs (~20% drop) due to higher employee and other expenses. The board also re-appointed M/s J V & Co as Internal Auditors and M/s Suryah & Dinesh Associates LLP as Secretarial Auditors for FY 2025-26. In-principle approval was given for a new Nephro Care Unit, while the Shanmuga Pharmacy & Diagnostics unit at Salem will close effective May 31, 2025. Statutory auditor PPN and Company issued an unmodified opinion, and IPO fund utilization showed nil deviation with Rs. 1,115.50 lakhs still in fixed deposits earmarked for capital expenditure.
Mixed signals for shareholders — revenue growth is positive but profit decline and unit closure raise concerns, while the planned Nephro Care Unit expansion and strong cash position (Rs. 1,258.93 lakhs) from the recent IPO could support future growth.